The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,501–1,600 of 1,810
Dai, B., Zhang, P., Wang, H., Sun, J. F., Zhang, Y., Xiao, Y., Liu, S., Cong, H., Li, Y., He, X., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1855104
Jiang, L., Shao, H., Wang, X., Wu, J., & Dong, F. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s590161
“12 Furthermore, the pathways connecting maternal and neonatal outcomes are not fully understood.”
Enrique Valdés, R. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006121
Zhang, T., Wang, S., Li, L., Zhu, A., & Wang, Q. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3922741
Olorunfemi, O., Ogbeye, G. B., Olowokere, A. E., & Irinoye, O. O. (2025) · Women and Children Nursing · doi:10.1016/j.wcn.2024.12.005 · Cited by 1
Nicodemus, N. A., Novero, V. M., Permadi, W., Suastika, K., Tan, A. T. B., Deerochanawong, C., Brand, K. M. G., Hanindita, M. C., & Markova, A. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2496430 · Cited by 2
“Around 60% of women with GDM develop type 2 diabetes (T2D) later in life 11 .”
Komariyah, S. (2025) · Judika (Jurnal Nusantara Medika) · doi:10.29407/judika.v9i1.25870
Zhang, H., Zhang, S., Liu, Y., Shi, J., Aijun, Y., Jin, R., Jin, Y., Wang, X., Fan, Y., Liu, Q., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.09.006
Lian, H., Yang, F., Song, X., Sun, T., Chen, Y., Ji, H., Chen, J., Yuan, W., Miao, M., Tu, X., et al. (2026) · ENGINEERING Environment · doi:10.1007/s11783-026-2236-3
“During pregnancy, maternal glycemic status undergoes numerous adaptions, including shifts in insulin sensitivity and regulation by placental hormones (e.g., estrogen and progesterone) (Newbern and Freemark, 2011; Plows et al., 2018).”
Muñoz-Nava, M. A., Araujo, M. E. F., Pérez-Luque, E. L., Cardona-Alvarado, M. I., Ramírez-Chávez, E., & Molina‐Torres, J. (2024) · Journal of Clinical Medical Research · doi:10.46889/jcmr.2024.5304
Patel, D., Rana, H., Thakkar, V. T., & Rabari, P. (2026) · Chemistry Africa · doi:10.1007/s42250-026-01732-7
“These medication groups are either supplied as monotherapy or in conjunction with other hypoglycaemics [7–13].”
Padvetnaya, V. U., Liegise, R., Sharma, R., Prabhu, M. P., Nagabharana, T., Suryanarayana, K. G., Krishnaveni, G. V., Matthews, S. G., & Kumaran, K. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109918
“21 Thus, India’s dual burden of high rates of adult CMDs and maternal, fetal and early childhood malnutrition is inextricably linked.”
Feng, J., Liu, S., Lai, R., Zhong, Z., Chen, Y., & Liang, W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1898511
Chalvan, S. P. M., Azarudeen, J. M., Kumar, P., Singh, M. F., & Ashok, B. S. (2025) · Journal of advanced health research & clinical medicine. · doi:10.4103/jhcr.jhcr_13_25
Wang, P., Gong, Z., Xue, Y., Gong, X., Guo, Y.-Q., Lu, Y., & Wang, Y. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02679-4
Zhou, Z., Huang, L., Sheng, L., Chen, W., Yang, C. C.-K., Xie, Y., Wang, Y., Chen, B., Ke, Y., & Wu, Z. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1803128
“Beyond impaired insulin resistance (IR) and glucose intolerance, GDM is characterized by low-grade systemic and placental inflammation (Plows et al., 2018).”
Advances in the Diagnosis and Treatment of Gestational Diabetes: From Mechanisms to Interventions
俞, 梦. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1682799
Chen, M., Sun, J., Yang, J., Wang, J., Shu, C., Zhang, L., Chai, X., & Dong, Y. (2026) · Medicine · doi:10.1097/md.0000000000048074
“[13] The exclusion criteria were as follows: (1) preexisting type 1 or type 2 diabetes.”
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
Repina, E. S., Kosteley, Y. V., Isakova, E. O., Skorokhodova, T. V., Bureev, A. S., & Yuriev, S. Y. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-212-4-55-63
Is placental immune polarization the missing link in gestational diabetes?
Triunfo, S. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-026-08390-7
Bariatric Surgery, Gestational Diabetes and Perinatal Outcomes: A Population‐Based Study
Weir, T., Ibiebele, I., Randall, D., Nippita, T. A. C., Torvaldsen, S., Gallimore, F., Morris, J. N., & Glastras, S. J. (2026) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.70226 · Cited by 1
Wadhwani, D., & Patel, S. S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116099
de Oliveira, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2021.tde-04052022-173940 · Cited by 2
Rahimi, Z., Cheraghian, B., Shahmansouri, M., Saki, N., Hashemi, S. J., Hosseini, S. A., Shahriari, A., Kaabi, J., & Nasehi, N. (2026) · Midwifery · doi:10.1016/j.midw.2026.104914
郭辉, Liu, S., Li, W., Feng, Y., Zhang, P., Li, C., Bai, S., 杨媛媛, Chen, X., Wang, S., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.124508
Deng, Y., Xu, C., Yang, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3118885/v1
Popova, P., Vasukova, E. A., Tkachuk, A. S., Anopova, A. D., Nemikina, I. S., Verbitskaya, E. V., Eriskovskaya, A. I., Vasilieva, E. Y., Zazerskaya, I. E., Bettikher, O. A., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113151
Mboudem, L. G. A., Kamani, S. L. P., Kamgaing, J. W., Douho, R. C. D., Nchouwet, M. L., & Ngnokam, S. L. W. (2026) · Comparative Clinical Pathology · doi:10.1007/s00580-026-03828-5
“It is well known that excessive production of reactive oxygen species during pregnancy affects placental development and efficiency, characterised by impaired transfer of energy substrates across the fetoplacental unit (Plows et al. 2018).”
Considerations for the Analysis of Urinary Environmental Chemical Concentrations During Pregnancy
Stevens, D. R., Hinton, K. M., O’Brien, K. M., Buckley, J. P., Welch, B. M., Watts, J. A., Calafat, A. M., Botelho, J. C., Sinkovskaya, E. S., Przybylska, A., et al. (2026) · Epidemiology · doi:10.1097/ede.0000000000001960
“30 Among uncontrolled diabetic patients, urine SG is expected to be higher, 13 as we observed for participants with gestational diabetes; we also observed a modestly lower UFR among these participants.”
Adipositas und Diabetes in der Schwangerschaft: Erkenntnisse aus der Mutter-Kind-Kohorte PEACHES
Schlune, A., Stupin, J. H., Schäfer-Graf, U. M., & Ensenauer, R. E. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01091-8 · Cited by 2
Rishi, V., Kandasamy, D., Gupta, Y., Sharma, R., Tandon, N., Goyal, A., Mehndiratta, A., Ganeshkumar, M., & Kalaivani, M. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04698-7 · Cited by 2
“Animal and post-mortem human studies indicate a possible role of decreased beta-cell mass and number in the pathophysiology of GDM, however other mechanisms including insulin resistance and complex neurohormonal dysfunction are also involved [ 25].”
Wang, J., Zhang, D., Hu, S., Guo, H., Zou, L., Wang, N., Xie, J., Wang, Z., Hao, M., Da, Y., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113510
Jung, Y. W., Lee, M., Ko, Y. B., Song, S. Y., Yoo, H. J., Kang, Y. E., Kim, O. S., Kang, B. H., & Kim, H. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4776287/v1
Yang, H., An, Y., Meng, J., & Xiao-mei, L. (2025) · Journal of Microencapsulation · doi:10.1080/02652048.2024.2423629
“Metabolic diseases such as type 2 diabetes, obesity, cardiovascular disease, and others are more common in infants whose mothers had gestational diabetes (Plows et al. 2018).”
STAT signaling pathway in pregnancy stages and related to complications
Aslanian‐Kalkhoran, L., Abbas-Kabiri, D., Afandideh, F., Badihi, E., Shahabirad, R., & Yousefi, M. (2026) · Cellular Immunology · doi:10.1016/j.cellimm.2026.105086
Cauduro, L. F. R. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.100.2024.tde-27052024-140106
Diabetes Mellitus and Antidiabetic Medications
Mirrakhimov, A. E. (2026) · Springer eBooks · doi:10.1007/978-3-032-29397-8_113
Research Progress on the Role of Vitamin D in Preventing Gestational Diabetes
Shi, F. (2025) · Highlights in Science Engineering and Technology · doi:10.54097/srcytz96
“During the first trimester, insulin sensitivity increases, but as pregnancy progresses, the increases in local hormones and those secreted by the placenta can bring about a condition of insulin resistance [14].”
Gaj-Hunter, A., Ruzik, A., Rajs, M., Przebieradło, P., Rędziniak, P., Żak, S., Kowalska, M., Żurek, K., Stolarska, K., & Terpiłowska, S. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6331
“[9] Pre-existing obesity amplifies these processes through chronic low-grade inflammation and altered adipokine profiles.”
InfluentialHimanshu, Verma, S., Yadav, S., Singh, A., Chauhan, J., Sameeksha, Sahu, K., & Mamgain, A. K. (2026) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-026-00025-4
“…sugars, and sugar-sweetened beverages with low fruit and vegetable consumption), tobacco use, excessive alcohol consumption, environmental pollutant exposure, adverse intra-uterine environment, psychosocial stress, depression, inadequate sleep, and characteristics of the built environment [28–41].”
Li, L., Li, L., Shao, Y., Du, R., Shi, X., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23606861
Thiam, S., Soumah, I. Y., Adourahmane, S., Diedhiou, F., Thorpe, D. F. K. S., Ramatoulaye, B., Tounkara, A. R., Médécé, A. H. H., Fatou, C. N., dande, D. N., et al. (2024) · Advances in Biochemistry · doi:10.11648/j.ab.20241203.11 · Cited by 1
Ueland, T., Michelsen, A. E., Qvigstad, E., Roland, M. C. P., Westerberg, A. C., Michelsen, T. M., Aukrust, P., Bollerslev, J., & Lekva, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1905877
“GDM has also been linked to impaired placental development (9, 10) and placental villi isolated from women with GDM display dysregulated expression of proteins involved in glucose metabolism, calcium-handling, in fl ammation and nutrient transport (11, 12).”
Vascular dysfunction at the crossroads of gestational diabetes mellitus and cancer
Silva, K., Valero, P., Fuentes, G. A., Cornejo, M., Aravena, D., Zamora, G., Espinoza, F., Vásquez, A., Rivas, J. C., Vergara, R., et al. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101500
Vasilj, O., Marinić, D., Trošt, T., & Žeželj, Z. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1938676
Yazbek, N., Absi, M. B., Tayeh, G. A., Gannagé‐Yared, M., & Ghorayeb, N. E. (2026) · BMC Public Health · doi:10.1186/s12889-026-28267-3
Şenkaya, A. R., & Öztekin, D. C. (2025) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20250444
“As the placenta grows and secretes increasing amounts of hormones, the pancreas may fail to produce sufficient insulin to maintain normal glucose levels, resulting in GDM. Women with normal glucose tolerance prior to pregnancy who develop GDM may have underlying glucose metabolism irregularities 5 .”
翁, 路. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141110
Enrique Valdés, R. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1007644
Investigation of the Sox-9 and Caspase-6 Immune Activity in Placentas of Pregnant Women with GDM
Öcal, E., Akalın, S. A., & Devecí, E. (2023) · Medical Records · doi:10.37990/medr.1252256
Gao, X.-L., Wei, Y.-T., & Xiao-yan, Y. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01986-x
“Gestational diabetes mellitus (GDM) denotes glucose meta - bolic intolerance that manifests or is identified during the ges - tational period, with a prevalence of approximately 16.5% among pregnancies worldwide and an upward trend fueled by the global obesity pandemic (Plows et al. 2018).”
InfluentialDur, R., Baş, A., & Dur, G. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05033-5
“Physiologically, pregnancy is Rıza Dur durriza@hotmail.com reflected by reduced NOS activity and elevated asymmetric dimethylarginine (ADMA), has been observed in women with GDM and correlates with poor vascular reactivity [8 , 9, 13].”
InfluentialXie, Y., Chen, B., Gao, S., Li, J., Chen, B., & Han, J. (2026) · Biomedicines · doi:10.3390/biomedicines14061322 · Cited by 1
“The renin-angiotensin-aldosterone system (RAAS) is also dysregulated, with elevated angiotensin II levels contributing to vasoconstriction and vascular smooth muscle proliferation [13,23].”
InfluentialGestational and postpartum maternal consequences of gestational diabetes mellitus
Wu, C.-K., Chang, C.-Y., Seow, K., Huang, Y.-C., Chuang, C.-W., & Chen, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1809244 · Cited by 1
“However, GDM occurs when pancreatic beta cells could not compensate for insulin resistance (4).”
Liu, Y., Li, X., Zhao, M., Zhao, Y., Zhou, Y., Yu, H., Zhao, K., Zhao, S., & Shang, X. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02546-8
“Gestational diabetes mellitus is a disorder of abnormal glucose tolerance that first occurs during pregnancy [ 3 , 14 ].”
Epidemiology and Pathophysiology of Diabetes and Obesity
Lennon, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-88835-9_1
Metabolic environment and epigenetic programming of the early embryo in rabbit
y Rada, R. V. (2022) · theses.fr (ABES) · doi:10.70675/536319d0z3a53z4da0z808cz9ab1c3f5ac7a
Diagnostic Value of Maternal Zonulin Levels in Fetal Growth Disorders
ÇELİK, S., Ürkmez, S. S., & Ürkmez, Y. C. (2026) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-2764-1615
Zhang, X., Wang, L., Han, X., Yin, J., Cao, H., Xu, J., & Tian, W. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02157-y · Cited by 1
“Gestational diabetes mellitus (GDM) is a prevalent metabolic disorder characterized by insulin resistance (IR), which poses significant risks to both maternal and neo-natal health [4, 25].”
Sex and Reproductive History as Nontraditional Risk Factors for PAD
Shea, J., Louche, C. D. D., Grainger, T., Dua, A., & Pouncey, A. L. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323040 · Cited by 1
The role of diabetes mellitus in the course and complications of pregnancy: A literature review
Akhmentayeva, D., Toktarova, Z., Izhanova, A. K., М.О., Т., Issabekova, A., & Zhansarina, G. K. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-426
Wen, X., Lu, H., Zhou, Y., Huang, M., & Xiao, Y. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120486
Khanam, S. M., Jahan, A., Runa, S. S., Jalil, R., Naznin, M. S., Sultana, S. R., Sharmin, F., & Munira, S. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20260539
Gusson, G. G., Tuffi, L. P., Perin, F. F., Maia, N. B., da Silva, R. P., Pavão, V. B. F., Pereira, A. R., SILVA, L. M. D. D., & Lopes, V. Q. B. (2023) · doi:10.56161/sci.ed.20230900c3
Wildey, A., Harrington, S., Stehno‐Bittel, L., & Karanu, F. (2024) · Regenerative Medicine · doi:10.2217/rme-2023-0187
Nikolaidis, G. F., Duarte, A., Griffin, S. C., & Lomas, J. R. S. (2024) · Emerald Group Publishing Limited eBooks · doi:10.1108/s0573-855520240000297005 · Cited by 2
Nakanga, W. P., Sekitoleko, I., Andrews, R. C., Hughes, A. E., Tino, S., Freathy, R. M., Shields, B., Lowe, W. L., Jones, A. G., Hattersley, A. T., et al. (2026) · BMJ Global Health · doi:10.1136/bmjgh-2025-019569 · Cited by 1
“30 31 In a study involving 1906 pregnant women in South Africa, FPG reading had a high sensitivity (83.3% (95% CI 77.0% to 88.5”
InfluentialAnalysis of comorbidity patterns of pregnancy and delivery complications in the female population
Zhang, X., Ma, X., Shan, S., Yao, X., Gu, Z., & Duan, Y. (2026) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2026.1824757
“These factors not only contribute to elevated blood glucose levels but also increase blood pressure (44, 45).”
Musinyali, V., Mokgopa, K. P., Mnyakeni‐Moleele, S. S., Tshiwawa, T., & Tshiluka, N. R. (2026) · Journal of Chemistry · doi:10.1155/joch/8193257
Penapisan dan Diagnosis Diabetes Melitus pada Pelayanan Kesehatan Primer
Nugraha, I. B. A. (2025) · Ganesha Medicine · doi:10.23887/gm.v5i1.92345
Research Progress on Influencing Factors of Brain Injury in Premature Infants
龙, 滔. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1281107
Meo, S. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21646-6.00009-5
Wang, C., Yang, Y., Zhang, Y., Wang, X., Sun, Y., Xu, M., & Pu, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1909211
Yakhlef, M., Aissani, F., Ayeche, R., Aggoune, N. E. I., Bouamine, S., & Boudalia, S. (2026) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v11i1.3104
“It has been reported that obesity reduces insulin sensitivity, leading to a rise of GDM risk by impairing insulin function and blood glucose control [29].”
Association between thyroid autoimmunity and gestational diabetes mellitus in euthyroid women
Sitoris, G., Poppe, K. G., Veltri, F., Ichiche, M., Kleynen, P., Praet, J., & Rozenberg, S. (2022) · Endocrine Abstracts · doi:10.1530/endoabs.81.p205
Advances in Selenium Research on Perinatal Disorders
冯, 学. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.161056
The problem of diabetes mellitus in obstetrics
Валериевна, П.-П. Е., Довгань, А. А., & Kulieva, E. R. (2024) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20242403125
Abera, D. A., Larbie, C., Mutocheluh, M., Dongsogo, J., Amonoo-Neizer, J., Ofosu, M., & Abugri, J. (2026) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2026.102399
Jankar, J. S., Manglaram, A., Ahmed, T., & Yadav, A. S. (2024) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2024.061
Lunghar, J., Deepa, M., Ram, U., Sagili, H., Jali, M. V., Pujar, Y. V., Chaudhari, U. K., Sachdeva, G., Joshi, S., Wagh, G. N., et al. (2026) · Journal of Diabetology · doi:10.4103/jod.jod_10_26
Vitamin D prevents gestational diabetes mellitus via modulating glycometabolismPreprint
Gu, S., Chen, X., & Liu, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3484166/v1
Jaihow, S., Pensuksan, W. C., Phasuk, N., Narkkul, U., Scholand, S. J., & Punsawad, C. (2025) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2025.2578122 · Cited by 2
“These findings can be explained in three ways: First, pregnant women of advanced age may develop hyperglycemia due to β-cell dysfunction and insulin resistance [23].”
Frequency of Diabetes Mellitus in Liver Cirrhosis Patients at Tertiary Care Hospital
Khattak, I. Q., Khan, R., Bibi, R., et al. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs20221612147
Félix, B., Ibrahim, Z., Nunes, M. L., Pichel, F., Gomes, A. R. T., Mendonça, A. F., Chung, C.-F., Verdezoto, N. X., & Nunes, F. (2026) · ACM Transactions on Computing for Healthcare · doi:10.1145/3827603
“2 Background 2.1 Gestational Diabetes, self-care, and self-monitoring Gestational Diabetes (GD) is a form of Diabetes Mellitus that develops during pregnancy due to hormonal changes, which cause a greater resistance to insulin [5, 111].”
InfluentialDecreased Serum Salusin-β Levels Are Independently Associated with Gestational Diabetes Mellitus
Sonay, H. Ö., Okuturlar, Y., Çokiçli, E., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14071602
“Previous studies have demonstrated endothelial dysfunction in GDM-affected pregnancies [21], and broader evidence indicates that GDM is characterized by immune–metabolic dysregulation rather than isolated hyperglycemia [4,22].”
Ghamri, K. A. (2024) · Cureus · doi:10.7759/cureus.61216 · Cited by 2
“Its pathophysiology is believed to be the result of impaired glucose tolerance due to pancreatic β -cell dysfunction on a background of chronic insulin resistance induced by multiple gestational hormones (i.e., mainly human placental lactogen) [2,3].”
Backgroundde Oliveira, M. E. G., Leite, C. E. D. V., Gaudêncio, C. C., Targino, E. D. S., Neri, J., Ramos, J. C. B. F., Barbosa, A. H. D., Barbosa, R. D. M., Torquato, S. C., & Veiga, D. K. E. (2023) · doi:10.56161/sci.ed.20230900c5
Retinal imaging in gestational diabetes mellitus: systematic review
Kitmiridou, D., Mitrogiannis, I., Charakida, M., & Nicolaides, K. H. (2026) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.70218 · Cited by 1
“In GDM, the combined effects of hyperglycemia, elevated leptin concentration and increased proinflammatory cytokines are thought to induce endothelial dysfunction, providing a plausible mechanism for the reported retinal venular enlargement and lower retinal arteriovenous ratio 27 .”
CDKAL1 gene polymorphism and susceptibility to gestational diabetes mellitus: a systematic review
Fayaz, F., Kaur, G., & Kaur, S. (2026) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-026-00901-0
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.